Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Aptamer Sciences patents insulin receptor-specific aptamers

Nov. 9, 2021

Researchers develop useful murine model of Bardet-Biedl syndrome

Nov. 9, 2021

Viking Therapeutics' dual GLP-1/GIP receptor agonists show potential in model of obesity

Nov. 8, 2021

Potent antiobesity effect seen with ZP-8396 in combination with semaglutide

Nov. 5, 2021

Chinese researchers present new glucose-lowering agents

Nov. 4, 2021

Structure-based optimization identifies potent galactokinase inhibitors

Nov. 3, 2021

Ndufv2 as a sex-specific genetic factor influencing mitochondrial functions

Nov. 2, 2021

Vertex Pharmaceuticals identifies new SERPINA1 polymerization inhibitors

Oct. 28, 2021

mLB-001 GeneRide vector restores hepatocyte function in MMA mice

Oct. 27, 2021

Novel split-intein-based gene therapy strategy to treat Wilson disease

Oct. 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...